Steven Santiago, MD

Chief Medical Officer
CareResource
Miami, Florida, United States

Disclosure(s): Gilead Sciences: Advisor/Consultant, Honoraria; Janssen: Honoraria

Presentation(s):

• 505 - Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort

  Saturday, October 19, 2024
  10:45 AM – 11:00 AM US PT